The Children’s Hospital of Philadelphia (CHOP) has been conducting a study on polyethylene glycol 3350 (PEG 3350), the active ingredient in MiraLAX, and its effect on a child’s brain. The study came about after reports that children have been experiencing behavioral problems after taking MiraLAX. If you are allergic to…
Articles Posted in Recalls
$7.25 Million Award for Defective Cochlear Implant
A Louisville, Kentucky jury awarded an eleven-year-old girl and her family $7.25 million dollars in compensatory and punitive damages as the result of a defective cochlear ear device. Born deaf, the little girl had a cochlear ear device implanted in her head when she was four years old. Four years…
CPSC Files a Complaint Over Buckyballs
CPSC Suit Against the Manufacturer of Buckyballs The Consumer Product Safety Commission (CPSC) has asked Buckyball manufacturer, Maxfield and Oberton, to stop sales of the Buckyball product, and to alert consumers that it is defective. Not only have they asked Maxfield and Oberton to stop sales, they have gone so…
Smith & Nephew Knee Replacement Defect Lawsuits
Smith & Nephew knee replacements are failing at an unacceptable rate Our lawyers are investigating knee replacement lawsuits against Smith & Nephew. These knee replacements have been on the market for some time. The reason for the lawsuits is simply: the Smith & Nephew knee replacements are simply failing at…
All-Metal Hip Replacements: No Advantage Over Older Implants
We recently reported on a study that revealed that the metal-on-metal hip replacements failed three times more often than other artificial hips. In fact, the U.S. Food and Drug Administration (FDA) ordered twenty-one (21) artificial hip manufacturers to conduct studies of the Metal-on-metal (MoM) hip replacement devices, and how they…
Topamax Lawsuit
Topamax, also known by its generic name topiramate, is an antiepileptic medication developed by Ortho-McNeil Pharmaceutical, a subsidiary of Johnson & Johnson. It was first approved by the U.S. Food and Drug Administration (FDA) in 1996. Initially, Topamax was primarily used for the treatment of epilepsy and seizures, as it…